1.              Alves CM, Reis CM, Hunt JA.  (2003).  Preliminary study on human protein adsorption and leukocyte adhesion to starch based biomaterials.  J. Materials Science: Materials in Medicine. 14, 157-165.

2.              Baldwin, L, Flanagan, BF, McLaughlin, PJ, Parkinson, RW, Hunt, JA and Williams, DF.  (2002).   A study of interface membranes from revision accord knee arthroplasty: the role of T lymphocytes.  Biomaterials 23, 3007-3014.

3.              Baldock C, Gilpin C, Koster A, Ziese U, Kadler KE, Kielty CM, Holmes DF.  (2002).  Three-dimensional reconstructions of extracellular matrix polymers using automated electron tomography.  J.Struct. Biol. 138, 130-135.

4.              Baldock C, Sherratt MJ, Shuttleworth CA & Kielty CM.  (2003).  The supramolecular organisation of collagen VI microfibrils.  J.Mol.Biol. 330, 297-307

5.              Ball SG, Bella J, Kielty CM & Shuttleworth CA. (2003).  Structural basis of type VI collagen dimer formation.  J.Biol.Chem. 278, 15326-15332.

6.              *Ball SG.  (2003).  What is a stem cell.  Biol.Sci.Rev. 16, 21-23

7.              Ball SG, & Kielty CM (2004).  Bone marrow mesenchymal stem cell differentiation into smooth muscle cells: roles of PDGF a receptor signaling and VEGF in SM a-actin filament organization. (submitted).

8.              Ball SG, Shuttleworth CA & Kielty CM (2004).  Role of direct cell contact in mesenchymal stem cell fate.  Int.J.Biochem.Cell Biiol. 36, 714-727.

9.              Bax DV, Bernard SE, Lomas A, Morgan A, Shuttleworth CA, Humphries MJ & Kielty CM.(2003).  Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by α5β1 and αvβ3 integrins.  J.Biol.Chem 278, 34605-34616. 

10.          Bayat A., Bock O., Mrowietz U., Ollier W.E.R., Ferguson M.W.J. (2003) Genetic susceptibility in keloid disease and hypertrophic scarring Transforming growth factor beta one (TGFb1) common polymorphisms and plasma levels in keloid disease and hypertrophic scarring".  Plastic and Reconstructive Surgery, 111, 535-546.

11.          Bayat, A., Walter, J.M., Lamb, H., Ferguson, M.W.J., Ollier, W.E.R.(2003) Rapid denaturing high performance liquid chromatography (DHPLC) for mutation screening of the transforming growth factor β3 gene using a novel proof reading polymerase. European Journal of Immunogenetics, 30, 1-6.

12.          *Bayat A., McGrouther D.A., Ferguson M.W.J. (2003) Skin scarring.  British Medical Journal, 326, 88-92.

13.          Bayat, A., Watson, J.S., Stanley, J.K., Ferguson, M.W.J., Ollier, W.E.R. (2003) Genetic susceptibility to Dupuytren's disease: association of Zf9 transcription factor gene.

14.          Plastic and Reconstructive Surgery;111:2133-21399.

15.          Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE.(2003) Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease. British Journal of Plastic Surgery. 56:328-334.

16.          Bayat A, Ollier WER, Ferguson MWJ and McGrouther DA.  (2003).  “Aggressive Keloid”: a severe variant of familial keloid scarring.  J R Soc Med, 96, 554-555.

17.          Beare AH, O'Kane S, Krane SM and Ferguson MWJ. (2003) Severely impaired wound healing in the collagenase-resistant mouse. J Invest Dermatol.120(1):153-63.

18.          Bennett WR, Crew TE, Slack JM, Ward A. (2003) Structural-proliferative units and organ growth: effects of insulin-like growth factor 2 on the growth of colon and skin. Development. 130(6):1079-88

19.          Bernacca, G.M., O’Connor, B., Williams D.F., Wheatley, D.J. Hydrodynamics function of polyurethane prosthetic heart valves: influences of Young’s modulus and leaflet thickness, Biomaterials, 2002, 23, 45-50.

20.          Bloor DJ, Metcalfe AD, Rutherford A, Brison DR, Kimber SJ. (2002) Expression of cell adhesion molecules during human preimplantation embryo development. Mol Hum Reprod. 8(3):237-45.

21.          *Brison DR, Metcalfe AD, Bloor DJ, Hunter HR, Brady G, Kimber SJ.  (2003).  Analysis of apoptosis in the preimplantation embryo.  In: A Laboratory Guide of the Preimplantation Mouse Embryo. (Gardner DK, Lane M, Watson AJ, eds).  In press.

22.          Buckley KA, Golding SL, Rice JM, Dillon JP, Gallagher JA (2003).  Release and interconversion of P2 receptor agonists by human osteoblast-like cells.  FASEB J. 17, 1401-1410

23.          Bujan J, Gimeno MJ, Jimenez JA, Kielty CM, Mecham RP, Bellon JM.  (2003).  Expression of elastic components in healthy and varicose veins.  World J.Surg. 27, 901-905.

24.          Cain S, Rock MJ, Freeman L, Baldock C, Morgan A, Mellody K, Sherratt MJ, Marson A, Shuttleworth CA, Weiss AS, Kielty CM.  (2003).  Molecular basis of elastic fibre formation: critical interactions and a tropoelastin – fibrillin -1- crosslink.  EMBO J (submitted).

25.          Cain S, Rock MJ, Mellody K, Freeman L, Marson A, Baldock C, Shuttleowrth CA & Kielty CM (2004).  Mass spectrometry analysis of fibrillin microfibril composition and organization.  J.Mol.Biol (in review).

26.          Callaghan JT, Hunt JA, Sutcliffe CJ, Morgan RH, Halford B, Black RA.  (2003). Bone growth model for the assessment of implant surface topology.  Biomaterials (submitted).

27.          Canfield AE, Farrington C, Dziobon MD, Boot-Handford RP, Heagerty AM, Kumar SN, Roberts ISD.  (2002).  The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study.  J.Path. 196, 228-234.

28.          Charalambous M, Smith FM, Bennett WR, et.al.  (2003). Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism.  Proceedings of the National Academy of Sciences (USA).  100, 14, 8292-8297.

29.          Collett G, Wood A, Alexander MY, Varnum BC, Boot-Handford RP, Ohanian V, Ohanian J, Fridell YW, Canfield AE.  (2003).  Receptor tyrosine kinase Axl regulates the osteogenic differentiation of pericytes.  Circ.Res. 92, 1123-1129.

30.          Crew T, Bennett B, Kelly S. et.al. (2003)  Combined effects of insulin-like growth factor 2 excess and tumour suppressor loss in overgrowth and cancer,  Genetical Research, 81, 3, 237.

31.          Curran SJ, Black RA.  (2001).  Mass Transport and Hydrodynamic Modelling for an Annular Flow Bioreactor.  Advances in Bioengineering, ASME BED-Vol.51.

32.          *Curran SJ, Black RA. (2003).  Taylor Vortex Bioreactors for Enhanced Mass Transport, in Tissue Engineering Bioreactors Principles, Design and Operation, Al-Rubeai M, Chaudhuri JB (Eds), Kluwer Academic Publishers (in press).

33.          Curran SJ, Black RA.  (2003).  Quantitative experimental study of shear stresses and mixing in progressive flow regimes within annular-flow bioreactors.  Chem.Eng.Sci (In Press).

34.          Diagne I, Hall SM, Kogake S, Kielty CM, Haworth SG.  (2003).  Paxillin associated focal adhesion involvement in perinatal pulmonary arterial remodelling.  Matrix Biol. 22, 193-205.

35.          Farrington Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE.  (2003).  Chondrogenic and adipogenic potential of microvascular pericytes.  Circulation, (submitted).

36.          Feugier P, Black RA, Hunt JA and How TV (in press). Attachment, morphology and adherence of human endothelial cells to vascular prosthesis materials under the action of shear stress. Biomaterials.

37.          *Fisher, RK, How, TV, Black, RA and Harris, PL.  Experimental evaluation of the haemodynamics of peripheral arterial bypass grafts.  In: Vascular Grafts: Experiment and Modelling, Andrea Tura (Ed) WIT Press, 2003, 151-191.

38.          Flasza M, Gorman P, Roylance R, Canfield AE, Baron M.  (2002).  Alternative splicing determines the domain structure of WWP1, a Nedd4 family protein.  Biochem Biophys Res Commun, 290, 431-437.

39.          Freemont AJ, Watkins A, Le Maitre C, Jeziorska M, Hoyland JA.  (2002).  Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. J Pathol. 196, 374-9.

40.          Freemont, AJ, Jeziorska, M, Hoyland, JA, Rooney, P, Kumar, S. (2002).  Mast cells in the pathogenesis of chronic back pain: a hypothesis.  J.Pathol. 197, 281-5

41.          Freemont, AJ, Watkins, A, Le Maitre, C, Baird, P, Jeziorska, M, Knight, MTN, Ross, ERS, O’Brien, JP, Hoyland, JA.  (2002).  Nerve growth factor expression and innervation of the painful intervertebral disc.  J Pathol. 197, 286-92

42.          Ghosh J, Murphy M, Turner N, Khwaja N, Halka A, Kielty CM & Walker MG. (2004). The role of transforming growth factor beta in the vascular system.  J.Vasc.Surg. (submitted).

43.          Ghosh J, Walker MG & Kielty CM (2004).  The influence of fluid shear forces on human coronary artery smooth muscle cells.  (submitted to Circulation Research).

44.          Goodstone NJ, Hardingham TE (2002) Tumour necrosis factor alpha is a more potent inducer of nitric oxide synthase than interleukin-1 beta in porcine articular chondrocytes. Rheumatology 41, 883-891

45.          Hardingham T, Tew S, Murdoch A (2002) Tissue Engineering: Chondrocytes and Cartilage. Arthritis Research 4 (suppl 3), 63-68

46.          *Hardingham T, Heng BC, Gribbon P (2002) Analysis of the concentrated solution properties of hyaluronan by confocal-FRAP show no evidence of chain-chain association. Hyaluronan, Vol 1, Chemistry, Biochemistry and Cell Biology, Eds JF Kennedy, GO Phillips, PA Williams and V Hascall, Woodhead, Cambridge, UK, 2002, pp 123-126

47.          *Hardingham TE.  (2003).  UK Centre for Tissue Engineering.  Bioventure, Vol.3, 16-19.

48.          *Hardingham TE.  (2003).  Regional Perspectives on Tissue Engineering: View from a Small Island.  Tissue Engineering, 9, 1063-1064.

49.          *Hardingham TE, Kielty CM, Canfield AE.  (2004).  Cell Culture in Tissue Engineering.  (Stacey G. Ed.).  Wiley (in press).

50.          Hundal K, Watkins A, Le Maitre CL, Freemont AJ, Hoyland JA (2002).  Chondrocyte senescence in intervertebral disc degeneration.  Journal of Pathology, 198, 51A-51A.

51.          Haston JL, Engelsen SB, Roessle M, Clarkson J, Blanch EW, Baldock C, Kielty CM, Wess TJ.  (2002).  Raman spectroscopy and X-ray diffraction: a combined study of fibrillin-rich microfibrillar elasticity.  J.Biol.Chem. 278, 41189-41197.

52.          *Hunt JA.  Encyclopaedia of Materials: Science and Technology.  Editor: DF Williams.  Chapter: Inflammation .  Pergamon Press, Elsevier Science, Amsterdam.  4068-4075.  2001.

53.          *Hunt JA.  (2003).  Encyclopaedia of Biomaterials and Biomedical Engineering.  Editors: GE Wnek and GL Bowlin.  Chapter: Foreign Body Response.  Marcel Dekker, New York.  In press.

54.          *Hunt JA.  (2003).  Biopolymer Methods in Tissue Engineering.  Editors: P Hatton and A Hollander.  Cell Attachment Assays.  The Humana Press Inc. Totowa.  In press.

55.          *Hunt JA and Shoicet MS (2001).  Biomaterials: surface interactions.  Current Opinion in Solid State & Materials Science, Vol. 5, Issues 2-3, 161-162.

56.          *Hunt, JA, and Shoichet, MS.  (2002).  Biomaterials: drug delivery systems, Current Opinion in Solid State & Materials Science, 6, 281.

57.          *Kielty CM, Sherratt MJ, Shuttleworth CA.  (2002).  Elastic fibres.  J.Cell Sci. 115, 2817-2828.

58.          *Kielty CM and Grant ME. (2002).  The collagen family: structure, assembly and organisation in the extracellular matrix.  In ‘Connective Tissue and its Heritable Diseases;  Molecular, Genetic and Medical Aspects’  (Royce PM and Steinmann B. Eds.).  Wiley-Liss, New York, p159-221.

59.          *Kielty CM.  (2003). Fibrillin: from microfibril assembly to biomechanical function.  Chapter in ‘Elastomeric Proteins’ (Shewry P and Bailey AJ. Eds.).  Royal Society Discussion Meeting.  Cambridge University Press (in press).

60.          *Kielty CM, Sherratt MJ, Haston JL, Wess TJ, Shuttleworth CA.  (2003).  Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix.  J. Muscle Research and Cell Motility. (invited chapter).  23, 581-596.

61.          *Kielty CM, Wess TJ, Haston JL, Sherratt MJ, Baldock C, Shuttleworth CA.  (2004).  Organisation and biomechanical properties of fibrillin microfibrils.  In ‘Marfan Syndrome’, Landes Bioscience/Eurekah.com (in press).

62.          *Kielty CM, Bax DV, Hodson N, Sherratt MJ. (2004).  Elastic fibre molecules in vascular tissue engineering.  In ‘Surfaces and Interfaces in Biomaterials’ (Vadgama P, Ed.).  Woodhead Publishing Ltd. (in press).

63.          Kielty CM.  Guest Editor, Directed Stem Cell Issue, Int.J.Biochem.Cell  Biol. April, 2004

64.          Kielty CM, Baldock C, Rock MJ, Ashworth JL, Shuttleworth CA. (2002).  Fibrillin: from microfibril assembly to biomechanical function.  Phil.Trans.R.Soc.Lond. B 357, 207-217.

65.          Kolettas E, Muir HI, Barrett JC, Hardingham TE.  (2001).  Chondrocyte phenotype and survival are regulated by culture conditions and by specific cytokines through the expression of SOX9.  Rheumatology, 40, 1146-1156.

66.          Le Maitre CL, Rajpura A, Staley W, Byers RJ, Ross R, Knight M, Freemont AJ, Hoyland JA.  (2001).  In Vitro gene transfer to human intervertebral disc chondrocytes by an adenovirus vector.  Journal of Pathology, 193, 1A-1A.

67.          Le Maitre CL, Baird P, Williamson B, Ross R, Freemont AJ, Hoyland JA.  (2003).  Expression of the IL-1 family in human intervertebral disc.  J.Pathol. 201: 56A-56A Suppl.

68.          Le Maitre CL, Williamson B, Ross R, Freemont AJ, Hoyland JA.  (2003).  Response of human intervertebral disc cells to IL-1.  J.Pathol.  201: 56A-56A Suppl.

69.          Le Maitre CL, Hoyland JA, Freemont AJ. (2004) Studies of human Intervertebral Disc Cell function in a constrained in vitro tissue culture system.  Spine, 29, 1187-1195.

70.          Le Maitre CL, Richardson SMA, Baird P, Williamson B, Ross R, Freemont AJ, Hoyland JA.  (2003).  IL-1: Role in Degeneration of the Intervertebral Disc and its inhibition using IL-Ra gene transfer.  Molecular Therapy, 7(5): S405-S405.

71.          Le Maitre CL, Freemont AJ, Hoyland JA. (2004).  Localisation of degradative enzymes and their inhibitors in the degenerate human intervertebral disc.  J Pathol 204, 47-54.

72.          Le Maitre CL, Rothwell NJ, Freemont AJ, Hoyland JA (2004).  Ex vivo gene therapy for disc degeneration.  J Pathol 204, 12A-12A Suppl.

73.          Li Y, Tew SR, Russell AM, Gonzalez K, Hardingham TE, Hawkins RE.  Transduction of human articular chondrocytes with adenoviral, retroviral and lentiviral vectors and the effects of enhanced expression of SOX9.  Tissue Engineering  (In press).

74.          Markkula, TK, Hunt, JA, Pu, FR, and Williams, RL.  (2002).  Surface Chemical Derivatisation of Plasma Treated PET and PTFE. Surface and Interface Analysis (SIA), 34, 583-58. 

75.          Marques, AP, Reis, RL, and Hunt, JA.  (2002).  The biocompatibility of novel starch based polymers and composites: in vitro studies. Biomaterials. 23, 1471-1478.

76.          Marson A, Rock MJ, Cain S, Baldock C, Shuttleworth CA & Kielty CM.  (2004).  Molecular basis of fibrillin-1 assembly.  (submitted to J.Biol.Chem.).

77.          Metcalfe AD, Bloor DJ, Lieberman BA, Kimber SJ and Brison DR. (2003) Amplification of representative cDNA pools from single human oocytes and pronucleate embryos. Mol Reprod Dev. 65(1):1-8.

78.          Metcalfe AD, Hunter HR, Bloor DJ, Liberman BA, Picton HM, Leese HJ, Kimber SJ and Brison DJ.  (2004).  Expression of 11 members of the BCL2 family of apoptosis regulatory molecules during human preimplantation embryo development and fragmentation.  Molecular Reproduction and Development, (In press).

79.          Michanetzis, GPA, Missirlis, YF, Rhodes, NP, Williams, DF, Eloy, R and Lemm, W.  (2002).  Influence of test protocol in determining the blood response to model polymers.  Journal of Materials Science: Materials in Medicine, 12, 757-765.

80.          Pu FR, Williams RL, Markkula T and Hunt JA (2001).  Monocyte adhesion and adhesion molecule expression on human endothelial cells on plasma treated PET and PTFE in vitro.  Materials in Medicine, 12, 971-977.

81.          Pu, FR, Williams, RL, Markkula, T, and  Hunt JA.  (2002).  Expression of Leukocyte-Endothelial Cell Adhesion Molecules on Monocyte Adhesion to Human Endothelial Cells on Plasma Treated PET and PTFE in vitro.  Biomaterials  23, 4705-4718. 

82.          Pu, FR, Williams, RL, Markkula, T. and  Hunt JA.  (2002).  Effect of plasma treated PET and PTFE on expression of adhesion molecules by human endothelial cells in vitro.  Biomaterials  23, 2411-2428. 

83.          Rajnoch C, Ferguson S, Metcalfe AD, Herrick SE, Willis HS and Ferguson MWJ. (2003) Regeneration of the ear following wounding in different mouse strains is dependent on the severity of wound trauma. Dev Dyn. 226(2):388-97.

84.          Rhodes NP, Srivastava JC, Longinotti C, Smith RF.  Heterogeneity in proliferative potential of ovine mesenchymal stem cell colonies.  Journal of Materials Science: Materials in Medicine.  In press.

85.          Rhodes NP, Srivastava JC, Longinotti C, and Smith RF.  Metabolic and histological analysis of mesenchymal stem cells grown in 3-dimensional hyaluronan-based scaffolds.  Journal of Materials Science: Materials in Medicine.  In press.

86.          Rice JM, Hunt JA, Gallagher JA.  Quantitative evaluation of the biocompatible and osteogenic properties of a range of biphasic calcium phosphate (BCP) granules using primary cultures of human osteoblasts and monocytes. (2003).  Calcified Tissue International, 72, 726-736.

87.          Rice JM, Hunt JA, Gallagher JA, Hanarp P, Sutherland DS, Gold J.  (2003).  Quantitative assessment of the response of primary derived human osteoblasts and macrophages to a range of nanotopography surfaces in a single culture model in vitro.  Biomaterials, 24, 4799-4818

88.          Rice JM, Hunt JA, Gallagher JA.  The response of primary human osteoblast/macrophage co-culture models to a range of Biphasic Calcium Phosphate granules with varying proportions of Tricalcium Phosphate in vitro.  Accepted Biomaterials 2003.

89.          Richardson, S, Le Maitre CL, Kielty C, Freemont AJ, Hoyland JA (2004).  Human bone marrow stromal cells as a source of cells for engineering human intervertebral disc.  J Pathol 204, 5A-5A Suppl.

90.          Rock MJ, Cain S, Freeman L, Baldock C, Morgan A, Mellody K, Sherratt MJ, Marson A, Shuttleworth CA, Weiss AS & Kielty CM.  (2004).  Molecular basis of elastic fibre formation: critical interactions and a tropoelastin – fibrilin-1-crosslink.  J.Biol.Chem. 279, 23748-23758

91.          Sherratt MJ, Holmes DF, Haston JL, Wess TJ, Shuttleworth CA & Kielty CM. (2003),  Fibrillin microfibrils are stiff reinforcing fibres in compliant tissues.  J.Mol.Biol. 332, 183-193.

92.          Sherratt MJ, Holmes DF, Shuttleworth CA, Kielty CM.  (2004).  Substrate dependent morphology of supra-molecular assemblies: fibrillin and type VI collagen microfibrils.  Biophys J, 86, 3211-3222.

93.          Sherratt MJ, Lu J & Kielty CM.  (2004).  Biomaterials surface chemistry influences fibrillin microfibril morphology. (submitted to Biophys. J.).

94.          Sinha S, Shuttleworth CA, Heagerty AM, Kielty CM.  (2002).  Expression of latent TGFbeta binding proteins and association with TGFbeta-1 and fibrillin-1 in the response to arterial injury.  Cardiovasc. Res. 53, 971-983.

95.          Sive JI, Baird P, Le Maitre CL, Hoyland JA, Freemont AJ.  (2001).  Investigation into the chondrocytic phenotype and pattern of aggrecan distribution in cells of the normal and degenerate intervertebral disc.  Journal of Pathology 195: 37A-37A.

96.          Sive, JI, Baird, P, Jeziorska, M, Watkins, A, Hoyland, JA, Freemont, AJ   (2002).  Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs.  Mol  Pathol, 55, 91-97

97.          Stephan S, Shuttleworth CA, & Kielty CM.  Expression and supramolecular assembly of recombinant α2(VIII) collagen homotrimers.  J. Biol. Chem.  279, 21469-21477.

98.          Swindle, EJ, Hunt, JA, Coleman, JW.  (2002).  A comparison of reactive oxygen species generation by rat peritoneal macrophages and mast cells using the highly sensitive real-time chemiluminescent probe Pholasin; inhibition of antigen-induced mast cell degranulation by macrophage-derived hydrogen peroxide.  Journal of Immunology, 169, 5866-5873.

99.          Tang ZG, Black RA, Curran JM, Hunt JA, Rhodes NP, Williams DF. (2003).  Surface properties and biocompatibility of solvent cast poly (e-caprolactone) films. Biomaterials, 25, 4741-4748

100.      Turner NJ, Kielty CM, Walker MG, Canfield AE.  (2003).  A novel hyaluronan biomaterial (Hyaff-11^®) as a scaffold for endothelial cells in tissue engineered vascular grafts.  Biomaterials (in press).

101.      Valentijn AJ, Metcalfe AD, Kott J, Streuli CH and Gilmore AP. (2003) Spatial and temporal changes in Bax subcellular localization during anoikis. J Cell Biol.;162(4):599-612.

102.      Vallabhaneni SR, Gilling-Smith GL, Brennan JA, Heyes RR, Hunt JA, How TV, Harris PL. (2003). Can monitoring of intrasac pressure accurately predict failure of endovascular aneurysm?  Journal of Endovascular Therapy.  10:524-530.

103.      *Williams, DF. (2002). The enabling technological advantages of chitin. Medical Device Technology, 13(1), 8-12.

104.      *Williams, DF. (2002).  Catheters, materials and infections.  Medical Device Technology, 13(2), 8-11.

105.      *Williams, DF. (2002).  Medical nanotechnology: how small can we go?  Medical Device Technology, 13(3), 7-9.

106.      *Williams, DF. (2002).  To test or not to test: the value of biological safety testing.  Medical Device Technology, 13(4), 8-10.

107.      *Williams, DF. (2002).  The philosophy, nature and nomenclature of tissue engineering and biomimetics.  Min. Invas. Ther & Allied Techno. 11, 87-92.

108.      *Williams, DF. (2002).  New metals for old,  Part 1: Benefits and Concerns. Medical Device Technology, 13(6), 11-13.

109.      *Williams, DF. (2002).  New metals for old, Part 2: Real and imaginary properties.  Medical Device Technology, 13(7), 7-9.

110.      *Williams, DF. (2002).  Public confidence in medical technology.  Medical Device Technology, 13(10), 11-13.

111.      *Williams, DF. The inert – bioactivity conundrum.  In Ellingsen, J-E. (Ed.)  The Implant Tissue Interface.  CRC Press, Boca Raton, (In Press).

112.      Williams D.F. Perspectives on the contributions of biomaterials and tissue engineering to bone repair, reconstruction and regeneration, In Bone Engineering, (ed) J.E.Davies, Em squared Incorporated, Toronto, 2001, 577-584.

113.      Williams D.F. Reconstructing the body, costs, prices and risks.  The Geneva Papers on Risk and Insurance, 2003, 28 (2), 331-338.

114.      *Williams D.F. The Japanese Approach to Tissue Engineering, The Royal Academy of Engineering, 2003.

115.      *Williams, DF.  Reassessing bioactive surfaces.  Medical Devices Technology (In Press). 

116.      Williams, DF. Biomaterials and tissue engineering in reconstructive surgery. In Sadhana Special Issue. 2003, 28, 563-574. 

117.      Williams RL, Wilson DJ and Rhodes NP.  Stability of plasma treated silicone rubber and its influence on blood compatibility.  Biomaterials.  In press. 

118.      Wilson DJ, Rhodes NP, Williams RL.  Surface modification of a segmented polyetherurethane using a low powered gas plasma and its influence on the activation of the coagulation system.  Biomaterials, 24, 5069-5081

Conference Abstracts

 

1.              Alves, CM, Reis, RL, Hunt, JA. (2002). Evaluation of Human Protein Adsorption onto Starch Based Biodegradable Materials: from Unitary to Complex Competitive Systems.  17^th European Society for Biomaterials.  Barcelona, September.

2.              Andrews KD, Black RA, Hunt JA and How TV.  (2001).  Electrostatic spinning for Tissue Engineering applications.  Proceedings of the ESB Congress, London 11^th-15^th September.

3.              Andrews KD, Black RA, Hunt JA (2003).  Cellular responses induced by electrostatically spun tissue engineering scaffolds.  18^th European Society for Biomaterials.  Stuttgart, October.

4.              Baldwin L, Flanagan BF, McLaughlin PJ, Parkinson RW, Darby A, Hunt JA.  (2001).  The Role of T Lymphocytes in the failure of Total Knee Arthroplasty.  ESB, London 12^th-14^th September. 

5.              Baldwin, L, Flanagan, BF, McLaughlin, Parkinson, RW, and Hunt JA. (2002).  Synovial Fluid Cytokines in Revision Knee Arthroplasty.  17^th European Society for Biomaterials.  Barcelona, September.

6.              Baldwin L, Rice JM, Hunt JA (2003).  The effect of inflammatory cytokines on mesenchymal stem cell differentiation for tissue engineering applications.  18^th European Conference on Biomaterials.  Stuttgart, October.

7.              Baldock C, Sherratt MJ, Shuttleworth CA and Kielty CM (2001).  Biomechanical properties of fibrillin-rich microfibrils.  Royal Soc. Meeting on Elastomeric Proteins.

8.              Baldock C, Sherratt MJ, Shuttleworth CA and Kielty CM.  (2003).  Structural analysis of collagen VI microfibrils.  BSMB, Oxford, UK.  March/April.

9.              Ball SG, Bella J, Kielty CM and Shuttleworth CA.  (2002).  Role of MIDAS sequences in intracellular collagen VI assembly.  Abstract and poster at Federation of European Connective Tissue Societies (FECTS) Meeting, Brighton, UK.  July

10.          Barley C, Shuttleworth CA and Kielty CM.  (2003).  The role of LTBP-3 in endochondral bone formation.  BSMB, Oxford, UK.  March/April.

11.          Beare AHM and Ferguson MWJ.  (2003).  Severely impaired wound healing in the collagenase resistant mouse.  Gordon Research Conference, Barga, Italy.

12.          Beare AHM and Ferguson MWJ (2003).  Severely impaired wound healing in the collagenase resistant mouse.  European Tissue Repair Society Meeting, Amsterdam.

13.          Bernard, S, Morgan, A, & Kielty, CM (2002) Integrin-mediated cell attachment to intact fibrillin-rich microfibrils. Keystone symposium, Colorado, USA. February.

14.          Bernard, SE, Lomas, A, Shuttleworth, CA & Kielty, CM (2002) Fibrillin-rich microfibrils as a ligand for dermal and vascular cells: adhesion, spreading and cellular consequences. Abstract (and talk) at Elastin 2002 Symposium, Italy, July.

15.          Black RA, Curran SJ.  (2003).  Improving mass transport in bioreactors for in vitro cartilage expansion and Tissue Engineering, Tissue Engineering of the Synovial Joint Components, Leeds 28^th Annual Biomaterials Meeting, 11^th January.

16.          Bluff J, Ireland G and Ferguson MWJ.  (2003).  The development and functionality of the cutaneous vasculature in murine incisional wounds.  Gordon Research Conference, Barga, Italy.

17.          Cain S, Morgan A, Shuttleworth CA and Kielty CM.  (2003).  Mass spectrometry analysis of isolated fibrillin-rich microfibrils.  Gordon Research Conference ‘Elastin and Elastic Fibres’, August.

18.          Callaghan, JT, Hunt, JA, Sutcliffe, CJ, Morgan, RH, Halford, B and Black, RA.  (2002).  Effect of CoCr Implant Macrostructure and Chemistry on Bone Growth in vitro.  17^th European Society for Biomaterials.  Barcelona, September.

19.          Charalambous M, Bennett WR, Smieth F. et.al.  (2003).  Growth regulation by Grb10. Genetical Research 81, 3, 236-236.

20.          Chen R, Hunt JA, Williams DF (2003).  Immobilised RGD peptides on silane-modified PLLA surface,  ETES, September.

21.          Chen R, Hunt JA, Williams DF.  (2003).  PLLA surface modified with RGD containing peptides.  TESi, Orlando, USA, December.

22.          Crouchley, C & Kielty, CM (2002) Isolation of adult human vascular stem cells. Abstract and poster at Federation of European Connective Tissue Societies (FECTS) meeting, Brighton July.

23.          Crouchley, CM, Ball, SG, Shuttleworth, CA & Kielty, CM (2003) Isolation of adult human vascular progenitor cells. BSMB, Oxford March/April.

24.          Curran, SJ, and Black, RA.  (2002).  Shear stress effects on freely suspended cells in an annular flow bioreactor.  Proceedings 17^th European Society for Biomaterials Conference.  Barcelona, Spain, 11^th-14^th September.

25.          Curran SJ and Black RA.  (2002).  Mass transport in an annular flow bioreactor for cell culture under dynamic mixing conditions.  Proceedings 17^th European Society for Biomaterials Conference.  Barcelona, Spain, 11^th-14^th September.

26.          Curran, SJ, Rice, JM, Chen, R. Hunt, JA, Rhodes, NP, Williams, DF, and Black, RA.  (2003).  Fluid Dynamics, Oxygen Transport and Cell Seeding Capabilities of Annular Flow Bioreactors for Tissue Engineering Applications.  29^th Annual Meeting of the Society For Biomaterials, Reno, Nevada, USA.. 30^th April-3^rd May.

27.          Curran SJ, Rice JM, Chen R, Donegan G, Williams DF, Hunt JA, Black RA. (2003).  Cell-seeding and proliferation on the lumina of PLLA tubules in a dynamic Couette-Taylor Bioreactor.  2^nd European Tissue Engineering Society Meeting, Genoa, Italy, 1^st-4^th September.

28.          Curran SJ, Rice JM, Chen R, Donegan G, Williams DF, Hunt JA, Black RA.  (2003).  Cell-seeding and expansion on the lumina of PLLA tubules in a novel 2-step dynamic bioreactor.  18^th European Society for Biomaterials.  Stuttgart, October.

29.          Curran SJ, Chen R, Rice JM, Hunt JA, Williams DF, Black RA.  (2003).  Novel bioreactor system for luminal cell-seeding and fluid mechanical stimulation of PLLA tubules.  TESi Annual Meeting, Orlando, FL, USA. December..

30.          Curran SJ, Rice JM, Chen R, Donegan G, Williams DF, Hunt JA, Black RA.  (2003).  Lumenal cell seeding and proliferation on PLLA tubes using dynamic Couette-Taylor bioreactors.  ETES.

31.          Curran SJ, Chen R, Hunt JM, Williams DF.  (2004).  Tissue Engineering Nascent Cartilage using Surface Modified PLLA Mircospheres in an Intermittent Stirred-Flow Bioreactor.  7^th World Congress on Biomaterials, Sydney, Australia.  May.

32.          Dallas SL, Jones CM, Barley C, Peters DM, Mosher DF, Bonewald LF, Humphries MJ and Kielty CM.  (2001).  Fibronectin is required for efficient  assembly of latent TGFβ binding protein-1 into the extracellular matrix.  Int. Association for Dental Research (IADR) Meeting.

33.          Diagne I, Hall SM, Kogake S, Kielty CM, Haworth SG.  (2001).  Activity of paxillin helps drive postnatal pulmonary arterial  remodelling.  Cardiology in the Young, 11:2.

34.          Donegan G, Hunt JA, Rhodes NP and Williams DF.  (2003).  The role of extracellular matrix in the hybrid tissue engineered vascular construct.  18^th Conference on Biomaterials, Stuttgart, October.

35.          Feugier, P, Black, RA, Hunt, JA and How, TV.  (2002).  Surface configuration determines adherence and behaviour of endothelial cells seeded on vascular prosthesis materials subjected to shear stress.  2^nd European Symposium of Vascular Biomaterials, Hamburg, Germany, 31^st November.

36.          Fletcher, JL, Ball, SG & Kielty, CM (2003) Selection of human vascular progenitor cells from bone marrow, and differentiation into smooth muscle-like cells. International Tissue Engineering meeting, Hilton Head, SC, USA (February/March).

37.          Freeman L, Mellody KM, Shuttleworth CA and Kielty CM.  (2002).  Fibrillin degradation by matrix metalloproteinases: further characterisation of cleavage sites in fibrillin-1 molecules and is assembled microfibrils.  Abstract at Elastin 2002 Symposium, Italy.  July.

38.          Freeman L, Rock MJ, Mellody K, Bax DV, Shuttleworth CA, Kogake S, Hall S, Haworth SG and Kielty CM.  (2003).  Fibrillin-1 interactions with elastic fibre molecules.  BSMB, Oxford, UK.  March/April.

39.          Freemont AJ, Hoyland JA, Rajpura A, Byers RJ, Bartley C, Jeriorska M, Knight M, Ross R, O’Brien J, Sutcliffe J, Le Maitre CL.  (2001).  Matrix degradation by chondrocytes in the intervertebral disc is mediated by Interleukin.  British Society for Rheumatology Annual General Meeting.  24^th-27^th April.

40.          Fujiyoshi KJA, Hunt JA.  (2003).  The effects of metal ions and dental endodontic sealant on the regulation of CXCR1, CXCR2 and CD11b expressions.  18^th European Society for Biomaterials.  Stuttgart, October.

41.          Ghosh, J, Walker, MG & Kielty, CM (2003) Expression of extracellular matrix and cytoskeletal molecules by vascular smooth muscle cells under shear stress. European Tissue Engineering Society (ETES) meeting, Italy, August.

42.          Grieve FM, Jones CJ, Le Maitre CL, Staley WA, Hoyland JA, Byers RJ.  (2001).  Chondrogenic transdifferentiation during osteoblastic differentiation of marrow stromal cells.  J.Pathol. 195, 10A.

43.          Grieve F. Jones CJ, Le Maitre CL, Staley WA, Hoyland JA, Byers RJ.  (2002).  Chondrogenic transdifferentiation during osteoblastic differentiation of marrow stromal cells.  Bone. 30, C14.

44.          Halford B, Sutcliffe CJ, Morgan RH, Callaghan J, Hunt JA, Black RA.  (2001).  Development of a process for the manufacture of high performance cementless orthopaedic prostheses with a novel biomaterial structure.  Time Compression Technologies, Manchester, 25^th-26^th September.

45.          Hundal K, Watkins A, Le Maitre CL, Freemont AJ, Hoyland JA.  (2002).  Chondrocyte senescence in intervertebral disc degeneration.  J.Pathol. 198, 51A.

46.          Hunt JA, Cooper JJ.  (2004).  HA-PLLA and PLLA interference screws in ACL reconstruction: in vivo model to study the tissue response.  Arthroscopy Association of North America.  April.

47.          Jackson P, Hunt JA, Knight J.  (2001).  Effect of Controlled Release Glass (C.R.G.) chemistry and particulate size on the neutrophil’s respiratory burst.  ESB, London, 12-14^th September.

48.          Jackson, PV, Hunt, JA, Doherty,PJ, Mobasheri, A, Cannon, AM, and Gilson, P.  (2003).  Cartilage Tissue Engineering: Culture Methods, Material Geometry and Chondrocyte Models.  Accepted to the American Society for Biomaterials Meeting.

49.          Jackson PV, Hunt JA, Doherty PJ, Cannon A, Gilson P.  (2003).  Hydrophilicity of 3-D biomaterials: The Washburn Equation.  18^th European Society for Biomaterials.  Stuttgart, October.

50.